Vascular

First-in-Man Study Demonstrates Safety and Efficacy of SELUTION™ DCB in Long Lesions

Findings confirm the efficacy of the SELUTION sirolimus-coated technology

A first patient has been treated in the EVAS2 IDE Confirmatory Clinical Study of the Nellix® EndoVascular Aneurysm Sealing system.

Endovascular stent graft study promises clinical results later this year

FDA allows study expansion and grants system “Breakthrough Device” status

Updated TCAR data from Silk Road Medical’s ROADSTER 1 and 2 studies presented at VEITH Symposium

Data Presented at 10th Society of Vascular and Interventional Annual Meeting

Seems the promise is realised as new clinical data suggests 3D stent technology outperforms straight comparator

High risk CLI patients avoid amputation at 12 months

Unique catheter-based device for the treatment of advanced PAD/Critical Limb Ischemia

Positive two year data reported from Nellix® EVAS FORWARD IDE Trial

First prospective clinical trial to evaluate endovascular aneurysm repair (EVAR) in women

Study paves the way for further sirolimus vs paclitaxel balloon trials below the knee

Results of ASTER study presented at International Stroke Conference

Additional funding from existing investors supports regulatory progress in USA and Japan

GORE® VIABAHN® VBX becomes the only device of its type to gain indication

PulseRider will complement Codman Neuro’s neurovascular portfolio of products for hemorrhagic and ischemic stroke.